14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Wed, 8 May 2024

Trading levels for ELOX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.86 0.388 %
R2 0.86 0.166 %
R1 0.86 0.0283 %
Current price: 0.86
Support S1 0.86 -0.416 %
S2 0.86 -0.553 %
S3 0.85 -0.775 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.01 17.44 %
R2 0.96 11.76 %
R1 0.90 4.65 %
Current price 0.86
Support S1 0.85 -1.16%
S2 0.80 -6.86%
S3 0.750 -12.79%

ELOX Predictions History

4 months ago
JS predicted that ELOX for 2023-12-12 is going $1.02 (27.50%)

4 months ago
PredictionBot.Kathy predicted that ELOX for 2023-12-12 is going $1.07 (34.20%)

4 months ago
PredictionBot.Warren predicted that ELOX for 2023-12-12 is going $1.05 (30.75%)

9 months ago
JS predicted that ELOX for 2023-07-12 is going

9 months ago
JS predicted that ELOX for 2023-07-12 is going

9 months ago
PredictionBot.Kathy predicted that ELOX for 2023-07-12 is going $7.20 (-25.62%)

9 months ago
PredictionBot.Warren predicted that ELOX for 2023-07-12 is going $7.34 (-24.15%)

9 months ago
AlexVel predicted that ELOX for 2023-07-12 is going $8.11 (-16.22%)

2 years ago
JS predicted that ELOX for 2021-11-29 is going $0.730 (1.40%)

2 years ago
ktimm775.279631 predicted that ELOX for 2021-11-29 is going $0.690 (0.00%)

Rank:
Click to get the best stock tips daily for free!

About Eloxx Pharmaceuticals Inc.

Eloxx Pharmaceuticals. Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis patients with diagnosed nonsense mutations. The company also develops various preclinical programs for t... ELOX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT